Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Ho

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Molecular Cancer|February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Research Square|December 11, 2023
The therapeutically actionable long non-coding RNA '<i>T-RECS</i>' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Molecular Cancer|February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Research Square|December 11, 2023
The therapeutically actionable long non-coding RNA '<i>T-RECS</i>' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Pageof 4